increasing serum troponin i and early prognosis in patients with chest pain or angina equivalent symptoms in the emergency department

Authors

hh davarani

m afzalimoghadam

h hosseinnejad

r hamidian

abstract

background: the purpose of this research was to determine the relation between negative or positive qualitative troponin i test and the short term prognosis of patients presenting to emergency department with chest pain or angina equivalent symptoms. methods: we assessed the qualitative rapid troponin i in patients with chest pain or angina equivalent symptoms after at least 4 hours and then we followed the patients in 72 hours after presentation for adverse events such as death, ccu admission, fatal arrhythmias and heart failure. results: after comparing qualitative troponin i test results and adverse events, we concluded that the troponin i was significantly more positive in patients with adverse events (i.e. ccu admission, fatal arrhythmias and heart failure) ( p =0.031). conclusion: a single measurement of  rapid qualitative troponin i test can be used as a prognostic factor in patients with chest pain or angina equivalent symptoms and also as a device for risk stratification of moderate and high risk patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Increasing Serum Troponin I and Early Prognosis in Patients with Chest Pain or Angina Equivalent Symptoms in the Emergency Department

BACKGROUND The purpose of this research was to determine the relation between negative or positive qualitative troponin I test and the short term prognosis of patients presenting to emergency department with chest pain or angina equivalent symptoms. METHODS we assessed the qualitative rapid troponin I in patients with chest pain or angina equivalent symptoms after at least 4 hours and then we...

full text

Chest pain and high troponin level without significant respiratory symptoms in young patients with COVID-19

Background: Of all patients infected with COVID-19, 95% have mild symptoms, but 5% may experience severe illness. There are reports of myocardial injury associated with the COVID19 infection in middle aged and old people with baseline cardiac conditions. Acute myocardial injury has been suggested as a marker for disease severity. Sometimes it is hard to differentiate between acute coronary synd...

full text

Will high-sensitivity troponin improve the evaluation of patients with chest pain in the emergency department?

s p g c Approximately 8 million people in the United States are evaluated for chest pain in the emergency department (ED) each year at an estimated cost of over $10 billion (1,2). Most of these individuals do not have an acute coronary syndrome (ACS). However, atypical symptoms of myocardial ischemia are common in certain patient subsets, and the initial electrocardiogram (ECG) is often normal ...

full text

Troponin I in patients without chest pain.

BACKGROUND Testing for troponin has important clinical value for patients who present with typical symptoms of acute coronary syndromes (ACS) such as chest pain (CP). Much less is known about the value of troponin testing for patients who present with other symptoms of ACS (anginal equivalent symptoms). METHODS The utilization and prognostic value of cardiac troponin I (cTnI) were evaluated a...

full text

Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain.

BACKGROUND Identification of patients with acute coronary syndromes (ACS) among those who present to emergency departments with possible myocardial ischemia is difficult. Myocardial perfusion imaging with 99mTc sestamibi and measurement of serum cardiac troponin I (cTnI) both can identify patients with ACS. METHODS AND RESULTS Patients considered at low to moderate risk for ACS underwent gate...

full text

Variation of cardiac troponin I and T measured with sensitive assays in emergency department patients with noncardiac chest pain.

BACKGROUND New-generation high-sensitivity assays for cardiac troponin have lower detection limits and less imprecision than earlier assays. Reference 99th-percentile cutoff values for these new assays are also lower, leading to higher frequencies of positive test results. When cardiac troponin concentrations are minimally increased, serial testing allows discrimination of myocardial infarction...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of public health

جلد ۴۱، شماره ۲، صفحات ۶۳-۶۹

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023